HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Budipine

HCID 68778
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
57982-78-2
Standard SMILES
CC(C)(C)N1CCC(c2ccccc2)(c2ccccc2)CC1
InChIKey
QIHLUZAFSSMXHQ-UHFFFAOYSA-N
Molecular formula
C21H27N
Average molar mass
293.4 g/mol
Monoisotopic mass
293.21434987

Overview

Budipine is a diarylmethane.

Names & identifiers

Preferred name
Budipine
IUPAC
1-tert-butyl-4,4-diphenylpiperidine
English name
BUDIPINE
Molecular formula
C21H27N
Molecular weight
293.45

Names & synonyms

Budipine57982-78-21-tert-Butyl-4,4-diphenylpiperidineBudipinumbudipino1-(1,1-Dimethylethyl)-4,4-diphenylpiperidineL9026OPI2ZPiperidine, 1-(1,1-dimethylethyl)-4,4-diphenyl-DTXSID20206709RefChem:121834DTXCID00129200N04BX03
Show more names
BUDIPINE USP/EP/BPBUDIPINE(FORR&DONLY)Budipine, 10 mM in DMSO4,4-diphenyl-1-tert-butyl-piperidine1-(1,1-dimethylethyl)-4,4-diphenyl-piperidinPiperidine,1-(1,1-dimethylethyl)-4,4-diphenyl-
261-062-41-(tert-Butyl)-4,4-diphenylpiperidine1-tert-Butyl-4,4-diphenyl-piperidineBudipine [INN]BudipinCHEMBL334491Budipine (INN)MFCD00866585

Database identifiers

CAS
57982-78-2
PubChem CID
68778
DTXSID
DTXSID20206709
ChEMBL
CHEMBL334491
ChEBI
CHEBI:135228
UNII
L9026OPI2Z
EC Number
261-062-4
Nikkaji
J14.641B

Properties

Computed structural properties

XLogP
5.2
Topological polar surface area
3.2 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
1
Rotatable bonds
3
Heavy atoms
22
Formal charge
0
Complexity
313

Experimental & physicochemical properties

DrugsPharmaceuticals

Physicochemical properties

Melting point
108.5 °C · 108.5°C
Boiling point
425.29 °C · 425.29°C (rough estimate)
Density
0.9665 · 0.9665 (rough estimate)
refractive index
1.49 · 1.4900 (estimate)
storage temp.
2 · 2-8°C
solubility
25 mg/mL · DMSO : 25 mg/mL (85.19 mM; Need ultrasonic)
form
Solid
pka
10.36 · 10.36±0.10(Predicted)
color
Light yellow to khaki
FDA UNII
9026 OPI2Z · L9026OPI2Z
ATC code
4 BX03 · N04BX03
Comptox DTXSID
20206709 · DTXSID20206709
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302-H315-H319-H332-H335
Precautionary statements
280 · P280-P305+P351+P338-P310

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

Signal word
Warning
Symbol(GHS)
GHS07
Hazard statements
H302-H315-H319-H332-H335
Precautionary statements
P280-P305+P351+P338-P310

Chemistry & industry

Pharmacology

ATC Code · 2 items

N - Nervous system

QN - Nervous system

MeSH Pharmacological ClassificationAgents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists.

Uses & manufacturing

UsesUse (kg; approx.) in Germany (2009): >10
Applications · 1 item

DescriptionParkinsan was launched in Germany as a centrally-active anti-Parkinsonian agent. It can be prepared in three steps: a Mannich-aldol sequence to assemble the 4-phenylpiperidine scaffold followed by a Friedel-Crafts reaction to introduce the second phenyl ring. Parkinsan is effective for the treatment of Parkinsonian tremors and is similar in action to, but more potent than, biperiden. It exhibits use-dependent, open channel, uncompetitive NMDA receptor antagonistic activity. This may occur by binding to the PCP site in addition to interacting with sigma, binding sites in the frontal cortex. Parkinsan is also an antagonist at presynaptic muscarinic autoreceptors but facilitation of direct or indirect dopaminergic transmission does not contribute to its actions. While its mechanism of action is not completely understood, it has a weak inhibitory effect on dopamine reuptake, inhibits evoked GABA release (with low affinity for GABA-A receptors and a lower affinity for benzodiazepine receptors), and has a weak inhibitory effect on MAO-B.

Upstream & downstream products

Upstream raw materials

Sodium hydroxideAluminum chloride

Additional notes

DefinitionChEBI: Budipine is a diarylmethane.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes